Gould Asset Management’s AbbVie ABBV Stock Holding History

Gould Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$570K	Buy	2,266 +1,120	+98%	+$241K	0.09%	106
2026 Q1	$249K	Buy	1,146 +70	+7%	+$15.5K	0.04%	160
2025 Q4	$246K	Sell	1,076 -697	-39%	-$159K	0.04%	154
2025 Q3	$411K	Sell	1,773 -89	-5%	-$18.1K	0.08%	119
2025 Q2	$346K	Buy	1,862 +569	+44%	+$106K	0.07%	127
2025 Q1	$271K	Hold	1,293	–	–	0.06%	137
2024 Q4	$230K	Buy	+1,293	New	+$238K	0.05%	150
2021 Q1	–	Sell	-2,033	Closed	-$218K	–	155
2020 Q4	$218K	Buy	+2,033	New	+$195K	0.07%	130
2019 Q4	–	Sell	-3,109	Closed	-$235K	–	147
2019 Q3	$235K	Buy	+3,109	New	+$213K	0.08%	125

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gould Asset Management's ABBV Position: Q2 2026 in Review

Gould Asset Management increased its AbbVie (ABBV) stake by 98% in Q2 2026, buying an estimated $241K and bringing the position to 2,266 shares worth $570K. The position accounts for 0.09% of the portfolio, ranked #106.

Gould Asset Management first reported a position in ABBV in Q3 2019 and has held it in 9 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gould Asset Management held 2,266 shares of AbbVie worth $570K as of Q2 2026.
Gould Asset Management bought 1,120 AbbVie shares in Q2 2026, an estimated $241K.
AbbVie made up 0.09% of Gould Asset Management's portfolio in Q2 2026, its #106 holding.
Gould Asset Management first reported a position in AbbVie in Q3 2019 and has held it in 9 quarters since.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gould Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.